Literature DB >> 29377983

Titin cardiomyopathy leads to altered mitochondrial energetics, increased fibrosis and long-term life-threatening arrhythmias.

Job A J Verdonschot1,2, Mark R Hazebroek1, Kasper W J Derks1,2, Arantxa Barandiarán Aizpurua1, Jort J Merken1, Ping Wang2, Jörgen Bierau2, Arthur van den Wijngaard2, Simon M Schalla1,3, Myrurgia A Abdul Hamid4, Marc van Bilsen1, Vanessa P M van Empel1, Christian Knackstedt1, Hans-Peter Brunner-La Rocca1, Han G Brunner2,5, Ingrid P C Krapels2, Stephane R B Heymans1,6,7.   

Abstract

Aims: Truncating titin variants (TTNtv) are the most prevalent genetic cause of dilated cardiomyopathy (DCM). We aim to study clinical parameters and long-term outcomes related to the TTNtv genotype and determine the related molecular changes at tissue level in TTNtv DCM patients. Methods and results: A total of 303 consecutive and extensively phenotyped DCM patients (including cardiac imaging, Holter monitoring, and endomyocardial biopsy) underwent DNA sequencing of 47 cardiomyopathy-associated genes including TTN, yielding 38 TTNtv positive (13%) patients. At long-term follow-up (median of 45 months, up to 12 years), TTNtv DCM patients had increased ventricular arrhythmias compared to other DCM, but a similar survival. Arrhythmias are especially prominent in TTNtv patients with an additional environmental trigger (i.e. virus infection, cardiac inflammation, systemic disease, toxic exposure). Importantly, cardiac mass is reduced in TTNtv patients, despite similar cardiac function and dimensions at cardiac magnetic resonance. These enhanced life-threatening arrhythmias and decreased cardiac mass in TTNtv DCM patients go along with significant cardiac energetic and matrix alterations. All components of the mitochondrial electron transport chain are significantly upregulated in TTNtv hearts at RNA-sequencing. Also, interstitial fibrosis was augmented in TTNtv patients at histological and transcript level.
Conclusion: Truncating titin variants lead to pronounced cardiac alterations in mitochondrial function, with increased interstitial fibrosis and reduced hypertrophy. Those structural and metabolic alterations in TTNtv hearts go along with increased ventricular arrhythmias at long-term follow-up, with a similar survival and overall cardiac function.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29377983     DOI: 10.1093/eurheartj/ehx808

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  42 in total

1.  Genetic basis and molecular biology of cardiac arrhythmias in cardiomyopathies.

Authors:  Ali J Marian; Babken Asatryan; Xander H T Wehrens
Journal:  Cardiovasc Res       Date:  2020-07-15       Impact factor: 10.787

Review 2.  Complex roads from genotype to phenotype in dilated cardiomyopathy: scientific update from the Working Group of Myocardial Function of the European Society of Cardiology.

Authors:  Antoine Bondue; Eloisa Arbustini; Anna Bianco; Michele Ciccarelli; Dana Dawson; Matteo De Rosa; Nazha Hamdani; Denise Hilfiker-Kleiner; Benjamin Meder; Adelino F Leite-Moreira; Thomas Thum; Carlo G Tocchetti; Gilda Varricchi; Jolanda Van der Velden; Roddy Walsh; Stephane Heymans
Journal:  Cardiovasc Res       Date:  2018-08-01       Impact factor: 10.787

3.  Genomics-First Evaluation of Heart Disease Associated With Titin-Truncating Variants.

Authors:  Christopher M Haggerty; Scott M Damrauer; Michael G Levin; David Birtwell; David J Carey; Alicia M Golden; Dustin N Hartzel; Yirui Hu; Renae Judy; Melissa A Kelly; Rachel L Kember; H Lester Kirchner; Joseph B Leader; Lusha Liang; Chris McDermott-Roe; Apoorva Babu; Michael Morley; Zachariah Nealy; Thomas N Person; Arichanah Pulenthiran; Aeron Small; Diane T Smelser; Richard C Stahl; Amy C Sturm; Heather Williams; Aris Baras; Kenneth B Margulies; Thomas P Cappola; Frederick E Dewey; Anurag Verma; Xinyuang Zhang; Adolfo Correa; Michael E Hall; James G Wilson; Marylyn D Ritchie; Daniel J Rader; Michael F Murray; Brandon K Fornwalt; Zoltan Arany
Journal:  Circulation       Date:  2019-06-20       Impact factor: 29.690

Review 4.  Titin mutations and muscle disease.

Authors:  Dalma Kellermayer; John E Smith; Henk Granzier
Journal:  Pflugers Arch       Date:  2019-03-27       Impact factor: 3.657

5.  Ventricular Tachycardia in Dilated Cardiomyopathy: Is it Time for Genetic Testing in All Patients?

Authors:  Heajung L Nguyen; Marmar Vaseghi
Journal:  JACC Clin Electrophysiol       Date:  2020-09-10

6.  Whole exome sequencing in a large pedigree with DCM identifies a novel mutation in RBM20.

Authors:  Tomas Robyns; Rik Willems; Johan Van Cleemput; Shalini Jhangiani; Donna Muzny; Richard Gibbs; James R Lupski; Jeroen Breckpot; Koenraad Devriendt; Anniek Corveleyn
Journal:  Acta Cardiol       Date:  2019-10-04       Impact factor: 1.718

Review 7.  Genetics of Dilated Cardiomyopathy: Clinical Implications.

Authors:  A Paldino; G De Angelis; M Merlo; M Gigli; M Dal Ferro; G M Severini; L Mestroni; G Sinagra
Journal:  Curr Cardiol Rep       Date:  2018-08-13       Impact factor: 2.931

Review 8.  Advances in the role and mechanism of BAG3 in dilated cardiomyopathy.

Authors:  Leiling Liu; Kaijun Sun; Xiaojun Zhang; Ying Tang; Danyan Xu
Journal:  Heart Fail Rev       Date:  2021-01       Impact factor: 4.214

Review 9.  Emerging concepts in arrhythmogenic dilated cardiomyopathy.

Authors:  Thomas Zegkos; Theofilos Panagiotidis; Despoina Parcharidou; Georgios Efthimiadis
Journal:  Heart Fail Rev       Date:  2021-09       Impact factor: 4.214

Review 10.  Non-ischemic dilated cardiomyopathy and cardiac fibrosis.

Authors:  Bianca Olivia Cojan-Minzat; Alexandru Zlibut; Lucia Agoston-Coldea
Journal:  Heart Fail Rev       Date:  2021-09       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.